rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Dan Paterson

President and CEO

Company insider

Files Form 4 as: President and CEO, Verastem.

In numbers

Trades disclosed
125
Buys
5
Sells
57
Bought
$68K
Sold
$1.8M
Companies
1
Companies where not an officer
0
First trade
15 Jan 2013
Last trade
1 Oct 2026
Last filed
2 Oct 2026

Companies traded

Where they are an officer
VSTM VerastemDirector, Officer · Biotechnology · last 1 Oct 20265 buys · 57 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
100Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
1 Oct 2026filed 2 Oct 2026VSTM VerastemBiotechnologySEC FORM 4 Sold$353K44,121 at $8.00filing
30 Sep 2026filed 2 Oct 2026VSTM VerastemBiotechnologySEC FORM 4 Code A—106,893 at $0.00filing
3 Aug 2026filed 5 Aug 2026VSTM VerastemBiotechnologySEC FORM 4 Sold$7,5651,302 at $5.81filing
3 Aug 2026filed 5 Aug 2026VSTM VerastemBiotechnologySEC FORM 4 Sold$7,5651,302 at $5.81filing
22 Jun 2026filed 24 Jun 2026VSTM VerastemBiotechnologySEC FORM 4 Sold$87K20,871 at $4.18filing
22 Jun 2026filed 24 Jun 2026VSTM VerastemBiotechnologySEC FORM 4 Sold$87K20,871 at $4.18filing
4 May 2026filed 6 May 2026VSTM VerastemBiotechnologySEC FORM 4 Sold$4,691806 at $5.82filing
4 May 2026filed 6 May 2026VSTM VerastemBiotechnologySEC FORM 4 Sold$4,691806 at $5.82filing
4 Feb 2026filed 5 Feb 2026VSTM VerastemBiotechnologySEC FORM 4 Sold$6,489970 at $6.69filing
4 Feb 2026filed 5 Feb 2026VSTM VerastemBiotechnologySEC FORM 4 Sold$6,489970 at $6.69filing
21 Jan 2026filed 23 Jan 2026VSTM VerastemBiotechnologySEC FORM 4 Code A—213,785 at $0.00filing
21 Jan 2026filed 23 Jan 2026VSTM VerastemBiotechnologySEC FORM 4 Code A—213,785 at $0.00filing
12 Jan 2026filed 14 Jan 2026VSTM VerastemBiotechnologySEC FORM 4 Sold$74K10,321 at $7.16filing
12 Jan 2026filed 14 Jan 2026VSTM VerastemBiotechnologySEC FORM 4 Sold$74K10,321 at $7.16filing
16 Dec 2025filed 18 Dec 2025VSTM VerastemBiotechnologySEC FORM 4 Sold$3,592393 at $9.14filing
11 Dec 2025filed 12 Dec 2025VSTM VerastemBiotechnologySEC FORM 4 Sold$20K2,000 at $10.00filing
10 Dec 2025filed 12 Dec 2025VSTM VerastemBiotechnologySEC FORM 4 Sold$20K2,000 at $10.07filing
9 Dec 2025filed 9 Dec 2025VSTM VerastemBiotechnologySEC FORM 4 Sold$21K2,000 at $10.25filing
8 Dec 2025filed 9 Dec 2025VSTM VerastemBiotechnologySEC FORM 4 Sold$21K2,000 at $10.50filing
5 Dec 2025filed 9 Dec 2025VSTM VerastemBiotechnologySEC FORM 4 Sold$21K2,000 at $10.61filing

Sectors

Health Care62

Buys in green, sells in red, by the company’s sector.

Related people

Daniel CalkinsChief Financial Officer · Chief Financial Officer at Verastem, filing Form 4 there in the last year
Michael P. BaileyDirector · Director at Verastem, filing Form 4 there in the last year
John JohnsonDirector · Director at Verastem, filing Form 4 there in the last year
Brian M. StuglikDirector · Director at Verastem, filing Form 4 there in the last year
Anil KapurDirector · Director at Verastem, filing Form 4 there in the last year